Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP163041.RAwawbLlHsbMOQ2F8blSVCteEc6qkvn_pky2XSGf_DJAY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP163041.RAwawbLlHsbMOQ2F8blSVCteEc6qkvn_pky2XSGf_DJAY130_assertion type Assertion NP163041.RAwawbLlHsbMOQ2F8blSVCteEc6qkvn_pky2XSGf_DJAY130_head.
- NP163041.RAwawbLlHsbMOQ2F8blSVCteEc6qkvn_pky2XSGf_DJAY130_assertion description "[The influence of cytochrome oxidase CYP2A6, CYP2B6, and CYP2C9 polymorphisms on the plasma concentrations of valproic acid in epileptic patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP163041.RAwawbLlHsbMOQ2F8blSVCteEc6qkvn_pky2XSGf_DJAY130_provenance.
- NP163041.RAwawbLlHsbMOQ2F8blSVCteEc6qkvn_pky2XSGf_DJAY130_assertion evidence source_evidence_literature NP163041.RAwawbLlHsbMOQ2F8blSVCteEc6qkvn_pky2XSGf_DJAY130_provenance.
- NP163041.RAwawbLlHsbMOQ2F8blSVCteEc6qkvn_pky2XSGf_DJAY130_assertion SIO_000772 20089352 NP163041.RAwawbLlHsbMOQ2F8blSVCteEc6qkvn_pky2XSGf_DJAY130_provenance.
- NP163041.RAwawbLlHsbMOQ2F8blSVCteEc6qkvn_pky2XSGf_DJAY130_assertion wasDerivedFrom gad-20150221 NP163041.RAwawbLlHsbMOQ2F8blSVCteEc6qkvn_pky2XSGf_DJAY130_provenance.
- NP163041.RAwawbLlHsbMOQ2F8blSVCteEc6qkvn_pky2XSGf_DJAY130_assertion wasGeneratedBy ECO_0000203 NP163041.RAwawbLlHsbMOQ2F8blSVCteEc6qkvn_pky2XSGf_DJAY130_provenance.